文献速递生殖医学

高龄女性累计活产率与获卵数:一项纳入4500名38岁及以上女性的单中心分析

Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old.
PubMed 文献 · Hum Reprod · 2018-01-01

该单中心回顾性分析纳入2000年1月至2013年12月4570名38岁及以上不孕女性首次刺激周期及后续冻胚移植,按年龄分组评估累计活产率。结果显示累计活产率随年龄增长显著下降,38-39岁为25.9%,40-41岁为16.4%,42-43岁为7%,44岁及以上为1.2%;获卵数越多累计活产率越高,但此获益主要限于41岁及以下女性,44岁及以上女性无明确获益。

要点

  • 38岁及以上女性累计活产率随年龄增长显著下降,42-43岁下降最明显,44岁及以上仅1.2%。
  • 获卵数越多累计活产率越高,但获益主要见于41岁及以下女性。
  • 44岁及以上女性无论获卵数多少累计活产率均无获益,作者认为应劝阻其使用自身卵子进行IVF周期。

核心结论

  • 在38岁及以上女性中,获卵数与累计活产率显著相关,但额外获益主要限于41岁及以下女性;44岁及以上女性无论获卵数多少均无获益。

研究设计与样本

  • 本研究为大学附属三级中心的回顾性分析,纳入2000年1月至2013年12月在本中心接受首个周期的4570名38岁及以上不孕女性。
  • 按年龄分为四组:38-39岁组1875个周期,40-41岁组1380个周期,42-43岁组833个周期,44岁及以上组482个周期。
  • 累计活产率通过将新鲜周期获得的妊娠和活产与冻胚移植周期获得的妊娠和活产相加进行评估,并构建了按年龄和获卵数预测累计活产率的模型。

主要发现

  • 累计活产率随年龄增长显著下降:38-39岁组为25.9%,40-41岁组为16.4%,42-43岁组为7%,44岁及以上组为1.2%。
  • 获卵数越多累计活产率越高,但这一关系在41岁及以下女性中更明显,44岁及以上女性中未观察到明确获益。

临床怎么用

  • 作者认为,43岁以上女性无论获卵数多少累计活产率均无获益,应劝阻其使用自身卵子进行IVF周期。
  • 作者认为,对其他年龄组,应结合年龄和预期卵巢反应给出建议。

局限性

  • 局限性涉及研究的回顾性性质,但所采用的治疗方案间未观察到显著差异。
  • 其他潜在局限性包括80%的病例胚胎冷冻采用慢速冷冻,以及小部分患者仍有冷冻胚胎;但作者不预期这些问题有重要影响,因为慢速冷冻结果良好且与玻璃化冷冻无显著差异,且冻胚移植带来的额外获益非常有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there any relationship between the number of oocytes retrieved and cumulative live birth rates (CLBRs) in women of advanced age? SUMMARY ANSWER: CLBRs increase with the number of oocytes retrieved in women of advanced reproductive age up to 41 years old, the added value is minimal in women more than 41 years and futile in women 44 years or older. WHAT IS KNOWN ALREADY: CLBR is actually the most relevant outcome of IVF from patients' perspective. There are several studies that have analysed CLBR's but some of them have included several stimulation cycles, others have not included the frozen embryo transfers (FETs) in their analysis and none has focused on women of advanced reproductive age. We aimed to assess CLBR in women ≥38 years after a single stimulation cycle plus the subsequent frozen embryo transfers. STUDY DESIGN, SIZE, DURATION: This is a retrospective analysis carried out in a University-affiliated tertiary centre between January 2000 and December 2013. Overall, 4570 infertile women aged ≥38 years who underwent their first cycle in our centre were included. PARTICIPANT/MATERIALS, SETTING, METHODS: Patients were categorized in four age-groups: 38-39 years (G1 = 1875 cycles), 40-41 years (G2 = 1380 cycles), 42-43 years (G3 = 833 cycles) and ≥44 years (G4 = 482 cycles). CLBR's were evaluated by adding the pregnancies and live births achieved in the FET's to the ones obtained in the fresh cycle. In order to find out the actual effect of the number of oocytes retrieved in these patients, a predictive model of CLBR according to age and oocyte yield was built. MAIN RESULTS AND THE ROLE OF CHANCE: CLBRs significantly decrease with increasing age among women ≥38 years of age, with the most prominent and clinically relevant decline observed at 42-43 years old, and clear evidence for futility in women aged ≥44 years (25.9% at 38-39 years, 16.4% at 40-41 years, 7% at 42-43 years and 1.2% from 44 years onwards). The higher the number of oocytes retrieved, the higher the CLBR; however, this is more evident up to 41 years old and no clear benefit is observed from 44 years and beyond. LIMITATIONS, REASONS FOR CAUTION: Limitations are related to the retrospective nature of the study; however, no significant differences were observed in the treatment protocols used. Other potential limitations could be the fact that embryo cryopreservation was carried out with slow freezing in 80% of cases and that a small proportion of patients still have frozen embryos; nevertheless, we do not expect a relevant impact of these issues as slow freezing showed excellent results that did not differ significantly compared to vitrification and, on the other hand, the extra benefit coming from the FETs was very limited. WIDER IMPLICATIONS OF THE FINDINGS: The number of oocytes retrieved is significantly associated with CLBR also in women of advanced reproductive age. However, the added benefit appears to be restricted mainly in women up to 41 years old. Women over 43 do not experience any benefit in CLBR irrespective of the number of oocytes retrieved, and thus should be discouraged from doing an IVF cycle with their own oocytes; for the other age-groups, recommendations should be given considering the age and the expected ovarian response. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: NA.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Devesa M, Tur R, Rodríguez I, et al. Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old. Hum Reprod. 2018. PMID: 30272168. doi:10.1093/humrep/dey295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。